Related Experiment Video
Updated: Oct 7, 2025

11:22
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
30.1K
Gut Microbiota Diversity and Overweight/Obesity in Infancy: Results from a Nested Case-control Study
Hong Mei1, Neng Li2, Yan Zhang1
1Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430016, China.
Current Medical Science
|January 5, 2022
Summary
Infant gut microbiota diversity changes may influence early obesity development. This study compared gut microbes in twins at 1 and 6 months, finding differences linked to weight status.
Area of Science:
- Microbiome research
- Pediatric health
- Obesity studies
Background:
- Childhood obesity is a global health issue with complex causes.
- Previous research on gut microbiota and obesity has yielded conflicting results.
Purpose of the Study:
- To investigate the relationship between gut microbiota diversity and infant overweight/obesity.
- To analyze changes in gut microbiota composition during early infancy.
Main Methods:
- A nested case-control study using a twin birth cohort.
- Stool samples collected from 12 twin pairs at 1 and 6 months of age.
- Gut microbiota analyzed using 16S rRNA gene sequencing.
Main Results:
- Microbiota diversity was lower in 1-month-old infants compared to 6-month-old infants.
- Specific bacterial groups (Bifidobacterium, Lachnospiracea) were more abundant in 6-month-olds.
- Higher Clostridium sensu stricto abundance was observed in overweight/obese infants at 6 months.
Conclusions:
- Gut microbiota diversity shifts in infancy may play a role in early obesity development.
- Findings suggest potential early microbial markers for obesity risk.
More Related Videos
Related Concept Videos
Anatomy of the Intestines
83.9K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
83.9K
Obesity
672
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
672
Bulimia Nervosa
243
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
243
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
6
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
6

